Serotonin (5HT) is a pronociceptive mediator in the periphery, and evidence implicates involvement in trigeminal pain processing. However, the mechanism(s) by which 5HT modulates trigeminal nociceptors remains unclear. Trigeminal pain can be evoked by the transient receptor potential V1 channel (TRPV1), which is expressed by nociceptive trigeminal neurons and induces release of proinflammatory calcitonin gene-related peptide (CGRP). In our preclinical models, 5HT evoked thermal hyperalgesia and enhanced calcium influx and CGRP release from the TRPV1 population of trigeminal nociceptors. Whether this occurs in humans is unknown. As dental pulp is densely innervated by trigeminal nociceptors, routine tooth extractions offer a unique opportunity to examine whether 5HT enhances CGRP release from human nociceptors. Pulpal tissue was collected from 140 extracted molar teeth from men and women, and basal release samples were collected before treatment with saline or 5HT 100 lmol/L. CGRP release was then stimulated with the TRPV1 agonist capsaicin 1 lmol/L and quantitated by enzyme immunoassay. Additional samples were collected for Western blots to examine 5HT receptor expression. We report that 5HT induced a significant increase in capsaicin-evoked CGRP release, and that this enhancement was observed only in female dental pulp, with no effect of 5HT on male dental pulp. The greatest amount of CGRP release occurred in dental pulp from women in the luteal phase of the menstrual cycle. These results indicate that 5HT enhances capsaicin-evoked CGRP release from human trigeminal nociceptors in a sexually dimorphic manner providing a mechanistic basis for prevalence of trigeminal pain disorders in women.
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Introduction
As approximately 1 in 4 persons experiences persistent craniofacial pain mediated by the trigeminal system, such as toothache and temporomandibular joint disorder pain [30, 31] and approximately 10 million Americans experience migraine [40] . Craniofacial pain represents a prevalent and problematic burden, especially to the higher proportion of patients with improperly controlled pain [6, 19] . Interestingly, trigeminal pain is more prevalent in women compared with men. For instance, migraine is twice as prevalent in women [29, 30, 42] and varies across the menstrual cycle [41, 46] . However, it is unclear whether this sex difference in prevalence is due to biological differences, psychosocial differences, environmental differences, or to multiple factors.
The monoamine neurotransmitter serotonin (5HT) has been implicated in trigeminal pain, including migraine and masseter muscle pain [13, 14, 20, 23] , and 5HT is known to evoke hyperalgesia when injected into human tissues [4,13,14]. Therapeutics targeting the 5HT system have proved successful in treating some forms of trigeminal pain [2,10,16,38]. However, it remains unclear how 5HT modulates human trigeminal nociceptors. Preclinical animal models have provided insight into the mechanisms by which the trigeminal system mediates pain, and indicate that 5HT may regulate a subpopulation of trigeminal sensory neurons that express the transient receptor potential (TRPV1) ion channel, which is critical in transducing many noxious stimuli. TRPV1 is gated by thermal stimuli [7, 8, 12 
